Patent / Sep 01, 2013
Detoxification of Active Pharmaceutical Ingredients For Nano-Filtration
The invention describes the use of nanofiltration of org. solvents as a general platform for removing genotoxic impurities, also known as genotoxins, used as a reagent or formed during the synthesis of active pharmaceutical ingredients or their intermediates. The invention thus focuses, in particular, on the removal of the most common classes of genotoxic impurities using membranes.
Also in the Knowledge Center
/ Mar 09, 2022
Monofluoromethylation of complex pharmaceutical steroids using non-depleting reagentsRead more
/ Jun 20, 2022